We specifically focused our research on triple-negative breast cancer (TNBC) and found that genetic inhibition of NMT1 triggered both ER stress and oxidative stress, and therefore stimulating the JNK pathway to inhibit breast cancer progression. Here, MAPK8 is linked to breast carcinoma.